{"id":"tvr","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Fatigue"},{"rate":"10-20%","effect":"Headache"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"TVR is a non-nucleoside inhibitor of the NS5B polymerase, which is essential for the replication of the hepatitis C virus. By blocking this enzyme, TVR prevents the virus from replicating and reduces the viral load in the body.","oneSentence":"TVR is a protease inhibitor that works by blocking the replication of the hepatitis C virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:54:37.027Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis C"},{"name":"Hepatitis C genotype 1 infection"}]},"trialDetails":[{"nctId":"NCT07444957","phase":"","title":"Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease","status":"RECRUITING","sponsor":"Fundación Interhospitalaria para la Investigación Cardiovascular FIC","startDate":"2026-01-05","conditions":"Coronary Arterial Disease (CAD), NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Stable Angina, Unstable Angina, NSTEMI","enrollment":1118},{"nctId":"NCT07299773","phase":"","title":"Evaluation of Patients With Hypertensive Disorders of Pregnancy: An Ambispective Observational Study","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-01-01","conditions":"Preeclampsia, Preeclampsia (PE), Hypertensive Disorder of Pregnancy","enrollment":120},{"nctId":"NCT03466151","phase":"NA","title":"RESOLUTE ONYX China RCT Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medtronic Vascular","startDate":"2018-04-12","conditions":"Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases","enrollment":550},{"nctId":"NCT03471845","phase":"NA","title":"RESOLUTE ONYX China Single Arm Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medtronic Vascular","startDate":"2018-03-30","conditions":"Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases","enrollment":591},{"nctId":"NCT07170709","phase":"NA","title":"WBV Reflex Latency and Mechanical Load","status":"COMPLETED","sponsor":"Selim Sezikli","startDate":"2025-09-02","conditions":"Whole-body Vibration, Healthy Volunteers (HV), Muscle Contraction","enrollment":36},{"nctId":"NCT06633172","phase":"NA","title":"Laparoscopic Ventral Mesh Rectopexy Versus Trans-vaginal Repair for Anterior Rectocele.","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2021-04-01","conditions":"Rectocele, Anterior Rectocele","enrollment":40},{"nctId":"NCT06554119","phase":"","title":"Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"1999-01","conditions":"Tricuspid Valve Regurgitation; Complications, Longterm Outcome","enrollment":375},{"nctId":"NCT03118531","phase":"NA","title":"China Resolute Integrity 34/38 mm Study","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2017-04-17","conditions":"Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases","enrollment":40},{"nctId":"NCT06002321","phase":"","title":"Right Ventricular Dysfunction in Chronic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"University of Siena","startDate":"2023-09-01","conditions":"Chronic Heart Failure, Right Ventricular Dysfunction, Right Heart Failure","enrollment":1000},{"nctId":"NCT01909869","phase":"NA","title":"A Pilot First In Man Study of EXCEL-Ⅱto Treat the Patients With de Novo Coronary Artery Lesions","status":"COMPLETED","sponsor":"JW Medical Systems Ltd","startDate":"2013-01","conditions":"Ischemia, Coronary Artery Disease","enrollment":45},{"nctId":"NCT02333292","phase":"","title":"Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions","status":"COMPLETED","sponsor":"Valme University Hospital","startDate":"2014-12","conditions":"Chronic Hepatitis C Infection","enrollment":1128},{"nctId":"NCT05040191","phase":"NA","title":"The Effect of Haptic Interactive Virtual Reality on Nasogastric Tube Practice Teaching","status":"COMPLETED","sponsor":"University of Beykent","startDate":"2021-05-01","conditions":"Simulation, Nasogastric Tube","enrollment":90},{"nctId":"NCT00161993","phase":"PHASE2","title":"Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2002-06-13","conditions":"Primary Immunodeficiency Diseases (PID), Agammaglobulinemia, Hypogammaglobulinemia","enrollment":24},{"nctId":"NCT00162006","phase":"PHASE2","title":"Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2003-01-13","conditions":"Immune Thrombocytopenic Purpura (ITP)","enrollment":28},{"nctId":"NCT02537769","phase":"NA","title":"Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients","status":"RECRUITING","sponsor":"University of Washington","startDate":"2015-08","conditions":"Tricuspid Regurgitation, Heart Failure NYHA Class III, Heart Failure NYHA Class IV","enrollment":40},{"nctId":"NCT02375074","phase":"NA","title":"Supported Employment and Preventing Early Disability","status":"COMPLETED","sponsor":"NORCE Norwegian Research Centre AS","startDate":"2014-05","conditions":"Unemployment","enrollment":96},{"nctId":"NCT03424551","phase":"NA","title":"Vibration Induced Reflex Responses and Estimation of TVR","status":"COMPLETED","sponsor":"Istanbul Physical Medicine Rehabilitation Training and Research Hospital","startDate":"2018-01-23","conditions":"Muscle, Physiology","enrollment":40},{"nctId":"NCT01598090","phase":"PHASE3","title":"Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2012-06-14","conditions":"Hepatitis C Virus","enrollment":881},{"nctId":"NCT01913600","phase":"NA","title":"Resolute Integrity US Extended Length Sub-Study(RI US XL)","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2013-07","conditions":"Coronary Artery Disease","enrollment":56},{"nctId":"NCT01915628","phase":"","title":"e-BioMatrix Canada Registry","status":"COMPLETED","sponsor":"Biosensors Europe SA","startDate":"2013-05","conditions":"Device Related MACE and Bleeding","enrollment":535},{"nctId":"NCT01638507","phase":"NA","title":"An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2012-07","conditions":"Coronary Artery Disease","enrollment":230},{"nctId":"NCT02758509","phase":"","title":"Impact of Antiviral Therapy on Gastroesophageal Varices.","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2010-01-01","conditions":"Chronic Hepatitis C, Cirrhosis","enrollment":237},{"nctId":"NCT01994486","phase":"PHASE2","title":"Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1","status":"COMPLETED","sponsor":"University of Florida","startDate":"2013-12","conditions":"Hepatitis C, Chronic","enrollment":20},{"nctId":"NCT01243749","phase":"","title":"RESOLUTE China Registry:","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2010-12","conditions":"Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases","enrollment":1800},{"nctId":"NCT01334268","phase":"NA","title":"RESOLUTE China RCT","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2011-09","conditions":"Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases","enrollment":400},{"nctId":"NCT01482390","phase":"PHASE2","title":"A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-11-30","conditions":"Hepatitis C","enrollment":80},{"nctId":"NCT02006745","phase":"PHASE3","title":"Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)","status":"COMPLETED","sponsor":"St Stephens Aids Trust","startDate":"2014-01","conditions":"HIV","enrollment":20},{"nctId":"NCT03110718","phase":"NA","title":"Role of Armeo-Power and Muscle Vibration in Upper Limb Rehabilitation","status":"COMPLETED","sponsor":"IRCCS Centro Neurolesi Bonino Pulejo","startDate":"2015-01-02","conditions":"Stroke","enrollment":20},{"nctId":"NCT01563328","phase":"PHASE1","title":"A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2012-03-01","conditions":"Infection, Human Immunodeficiency Virus","enrollment":32},{"nctId":"NCT01132456","phase":"NA","title":"RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2010-06","conditions":"Ischemic Heart Disease, Coronary Stenosis, Cardiovascular Diseases","enrollment":312},{"nctId":"NCT00726453","phase":"NA","title":"The Medtronic RESOLUTE US Clinical Trial","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2008-07","conditions":"Coronary Artery Disease","enrollment":1516},{"nctId":"NCT01485991","phase":"PHASE3","title":"TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy","status":"COMPLETED","sponsor":"Janssen R&D Ireland","startDate":"2012-02","conditions":"Hepatitis C","enrollment":771},{"nctId":"NCT00997711","phase":"PHASE4","title":"Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the AsIAN Population","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2009-04","conditions":"Coronary Artery Disease","enrollment":953},{"nctId":"NCT02486861","phase":"","title":"OCT-Features in Culprit and Not Culprit Coronary Plaque in ACS Patients","status":"UNKNOWN","sponsor":"A.O.U. Città della Salute e della Scienza","startDate":"2015-05","conditions":"Acute Coronary Syndrome, Culprit Plaque, Non Culprit Plaque","enrollment":100},{"nctId":"NCT00927940","phase":"NA","title":"RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent","status":"COMPLETED","sponsor":"Medtronic Vascular","startDate":"2009-03","conditions":"Arterial Occlusive Diseases, Myocardial Ischemia, Cardiovascular Diseases","enrollment":100},{"nctId":"NCT01582035","phase":"PHASE1","title":"Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir","status":"COMPLETED","sponsor":"Janssen R&D Ireland","startDate":"2012-04","conditions":"Hepatitis C","enrollment":7},{"nctId":"NCT00561015","phase":"PHASE2","title":"A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection","status":"COMPLETED","sponsor":"Tibotec BVBA","startDate":"2007-12","conditions":"Hepatitis C, Chronic","enrollment":52},{"nctId":"NCT01336829","phase":"PHASE1","title":"TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.","status":"COMPLETED","sponsor":"Tibotec Pharmaceuticals, Ireland","startDate":"2011-03","conditions":"Hepatitis C, HIV","enrollment":33},{"nctId":"NCT00973388","phase":"PHASE1","title":"VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers","status":"COMPLETED","sponsor":"Tibotec BVBA","startDate":"2009-10","conditions":"Hepatitis C","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2600,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Telaprevir"],"phase":"phase_3","status":"active","brandName":"TVR","genericName":"TVR","companyName":"Janssen R&D Ireland","companyId":"janssen-r-d-ireland","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TVR is a protease inhibitor that works by blocking the replication of the hepatitis C virus. Used for Chronic hepatitis C, Hepatitis C genotype 1 infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}